UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:UNH) with a Neutral and raises the price target from $510 to $520.
UBS analyst Kevin Caliendo maintains UnitedHealth Group (NYSE:UNH) with a Neutral and raises the price target from $510 to $520.